To explore the expression of CD44 in FTC, Figge et al. reported that 56% (9 of 16 cases) of follicular adenomas (FAs) exhibited CD44 expression with plasma membrane staining. This evidence concerns the gene CD44 and thyroid cancer, nonmedullary, 2.